SNRPCP17

Across TCGA pan-cancer cohorts, SNRPCP17 RNA is linked to patient survival in 8 of 34 cancer types, making it the most broadly survival-associated SNRPCP17 data layer.

The strongest signal is observed in kidney renal clear cell carcinoma (KIRC), where higher SNRPCP17 RNA is associated with better disease-free survival. In most high-consensus cancer types, elevated SNRPCP17 expression acts as an unfavorable survival marker, although some lineages such as KIRC and LUAD show a favorable association.

KIRC, UVM, and COAD are the cancer types where SNRPCP17 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
KIRC	DFS	Tertile	All	0.922	0.855	.013	108	view →
UVM	DFS	Tertile	All	0.353	0.778	.004	72	view →
COAD	DFS	Tertile	II,III,IV	0.232	0.657	<.001	33	view →
TGCT	DFS	Quartile	II,III,IV	0.586	0.996	.002	30	view →
LUAD	OS	Tertile	All	0.677	0.326	.011	27	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
SKCM	OS	Tertile	III,IV	0.268	0.701	.009	9	view →
PRAD	OS	Tertile	All	0.946	0.996	.049	6	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

SNRPCP17–KIRC (DFS)

Open the KIRC breakdown →